Full Schedule

7:00 AM - 8:00 AM US PT

IDSA Business Meeting: Renewed Priorities for a New Era at IDSA

Location: 304 ABC

Event

8:00 AM - 9:00 AM US PT

9 - New ID Diagnostics in the Pipeline

This session will be available on demand after IDWeek.

This session will be live streamed during IDWeek.

Location: Petree C

Moderator: – Johns Hopkins School of Medicine

Moderator: – University of Utah School of Medicine

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTraineeTransplantCOVID-19

8:00 AM - 9:00 AM US PT

33 - The PhAST BC GN Assay: Rapid phenotypic AST for bloodstream infections

Location: Petree C

Speaker: – PhAST Corp.

8:00 AM - 9:00 AM US PT

34 - Deepull: Ullcore BSI test - One hour direct-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens and select resistant markers

Location: Petree C

Speaker: – Deepull, Barcelona Spain

8:00 AM - 9:00 AM US PT

35 - Pathogen Whole Genome Sequencing for Rapid ID & AST Directly from Multiple Clinical Sample Types

Location: Petree C

Speaker: – Ragon Institute of MGH, MIT and Harvard

8:00 AM - 9:00 AM US PT

10 - AAP Redbook: Highlights for 2024-2027

Location: 403 A

Moderator: – Emory University School of Medicine

Moderator: – Indiana University

Moderator: – University of Colorado School of Medicine and Children's Hospital Colorado

Epi & Infection ControlGlobal IDInvestigative IDPediatric IDTraineeTransplant

8:00 AM - 8:30 AM US PT

36 - AAP Redbook: Highlights for 2024-2027 Part 1

Location: 403 A

Speaker: – Indiana University

8:30 AM - 9:00 AM US PT

37 - AAP Redbook: Highlights for 2024-2027 Part 2

Location: 403 A

Speaker: – University of Colorado School of Medicine and Children's Hospital Colorado

8:00 AM - 9:00 AM US PT

11 - All Connected: Global Health Care Delivery and Product Development Impact on Domestic Infectious Diseases

Location: 502 A

Moderator: – University of Washington/Seattle Children's Hospital

Moderator: – CDC

Faculty: – Centers for Disease Control and Prevention

Faculty: – University of Virginia Medical Center

Adult IDEpi & Infection ControlPediatric IDTrainee

8:00 AM - 8:30 AM US PT

38 - Medical Tourist Beware! A Review of Recent Outbreaks Related to Medical Tourism

Location: 502 A

Speaker: – Centers for Disease Control and Prevention

8:30 AM - 9:00 AM US PT

39 - Anatomy of a Recall: Outbreaks Due to Product Contamination

Location: 502 A

Speaker: – University of Virginia Medical Center

8:00 AM - 9:00 AM US PT

12 - Bills, Bill, Bills (and ID): What’s New and Exciting in Billing and Coding

Location: 404 AB

Moderator: – University of Maryland Medical Center

Moderator: – ID CARE

Faculty: – Icahn School of Medicine at Mount Sinai

Faculty: – Indiana University School of Medicine

Faculty: – University of North Carolina

Adult IDTrainee

8:00 AM - 8:20 AM US PT

40 - Case based discussion on optimizing billing and coding to impact reimbursement and quality metrics

Location: 404 AB

Speaker: – Icahn School of Medicine at Mount Sinai

8:20 AM - 8:40 AM US PT

41 - Coding For Our Value--ID Complex Care

Location: 404 AB

Speaker: – Indiana University School of Medicine

8:40 AM - 9:00 AM US PT

42 - Practical methods to enhance ID physician reimbursement

Location: 404 AB

Speaker: – University of North Carolina

8:00 AM - 9:00 AM US PT

13 - Bronchiectasis and NTMs

Location: 515 A

Moderator:

Moderator: – Oregon State University

Faculty: – Georgetown University

Faculty: – National Jewish Health

Adult IDGlobal IDInvestigative IDPediatric IDTrainee

8:00 AM - 8:30 AM US PT

43 - Bronchiectasis Update

Location: 515 A

Speaker: – Georgetown University

8:30 AM - 9:00 AM US PT

44 - Current Treatment Approach for NTM lung Infection

Location: 515 A

Speaker: – National Jewish Health

8:00 AM - 9:00 AM US PT

14 - Double Trouble? Evaluating Beta-Lactams as Adjunctive Therapy for Difficult Gram-Positive Infections

Location: 408 B

Moderator: – University of Georgia College of Pharmacy

Moderator: – Penn Presbyterian Medical Center

Faculty: – University of Georgia College of Pharmacy

Faculty: – Intermountain Medical Center

Adult IDTrainee

8:00 AM - 8:30 AM US PT

45 - Beta-Lactam Adjunctive Therapy for Difficult Staphylococcus aureus Infections

Location: 408 B

Speaker: – University of Georgia College of Pharmacy

8:30 AM - 9:00 AM US PT

46 - Beta-Lactam Adjunctive Therapy for Difficult Enterococcal Infections

Location: 408 B

Speaker: – Intermountain Medical Center

8:00 AM - 9:00 AM US PT

15 - Peace of Mind: Optimizing Mental Health in the HIV Clinic

Location: 502 B

Moderator: – University of Alabama-Birmingham Heersink School of Medicine

Moderator: – DAP Health

Faculty: – University of California Los Angeles, David Geffen School of Medicine

Faculty: – CrescentCare

Adult IDEpi & Infection ControlGlobal IDHIV-STD-TBPediatric IDTrainee

8:00 AM - 8:30 AM US PT

47 - Utilizing Clinic-based Interventions to Re-engage the Struggling Patient

Location: 502 B

Speaker: – University of California Los Angeles, David Geffen School of Medicine

8:30 AM - 9:00 AM US PT

48 - Managing Depression and Anxiety in the HIV Clinic

Location: 502 B

Speaker: – CrescentCare

8:00 AM - 9:00 AM US PT

16 - Progress and Challenges in the Management of CNS Infections

Location: 403 B

Moderator: – Hospital Infantil de Mexico, Mexico and Instituto Conmemorativo de la Salud, Panama

Moderator: – CDC

Faculty: – UT Health Mc Govern Medical School

Faculty: – UT Southwestern Medical Center

Adult IDEpi & Infection ControlGlobal IDHIV-STD-TBPediatric IDTrainee

8:00 AM - 8:30 AM US PT

49 - Review of Progress and Challenges in Bacterial Meningitis and Encephalitis

Location: 403 B

Speaker: – UT Health Mc Govern Medical School

8:30 AM - 9:00 AM US PT

50 - Linking CNS Infection and Inflammation with Neurodegeneration

Location: 403 B

Speaker: – UT Southwestern Medical Center

8:00 AM - 9:00 AM US PT

17 - Should HCV Be Treated in Pregnant Persons?

Location: 408 A

Moderator: – Johns Hopkins University

Faculty: – University of Pittsburgh

Faculty: – Washington University in St. Louis

Adult IDGlobal IDInvestigative IDHIV-STD-TBTrainee

8:00 AM - 8:30 AM US PT

51 - What We Know So Far

Location: 408 A

Speaker: – University of Pittsburgh

8:30 AM - 9:00 AM US PT

52 - Implementation Successes and Challenges

Location: 408 A

Speaker: – Washington University in St. Louis

8:00 AM - 9:00 AM US PT

18 - Stewardship Metrics That Work: How Prescribing Practices Impact Patient Outcomes

Location: 515 B

Moderator: – Trinity Health Grand Rapids

Moderator: – Seattle Children's Hospital / University of Washington

Faculty: – VA Buffalo

Faculty: – University of Colorado School of Medicine

Adult IDEpi & Infection ControlPediatric IDTrainee

8:00 AM - 8:30 AM US PT

53 - Local Metrics to Push Stewardship Programs Forward

Location: 515 B

Speaker: – VA Buffalo

8:30 AM - 9:00 AM US PT

54 - Not Just Antibiotic Use: Patient Outcomes Data to Support Stewardship

Location: 515 B

Speaker: – University of Colorado School of Medicine

8:00 AM - 9:00 AM US PT

19 - What’s New in Medical Education?

Location: 411

Moderator: – University of Washington School of Medicine

Moderator: – Nationwide Children's Hospital/OSU

Faculty: – Baylor College of Medicine

Faculty: – Beth Israel Deaconess Medical Center & Boston Children's Hospital

Adult IDPediatric IDTrainee

8:00 AM - 8:30 AM US PT

55 - Educational Scholarship: Ripe Fruit on the Tree for Success as a Clinician Educator

Location: 411

Speaker: – Baylor College of Medicine

8:30 AM - 9:00 AM US PT

56 - Teaching ID by Podcast

Location: 411

Speaker: – Beth Israel Deaconess Medical Center & Boston Children's Hospital

8:30 AM - 8:55 AM US PT

Antibiotic Stewardship Staffing Practices: Experience from 3 Hospitals

Location: BugHub Stage

BugHub Stage

9:00 AM - 9:55 AM US PT

Bug of the Day

Location: BugHub Stage

Presenter: – University of Illinois at Chicago

Presenter: – Emory University School of Medicine

BugHub Stage

9:00 AM - 12:00 PM US PT

Professional Headshots

Location: NextGen ID Lounge (Hall K Foyer)

IDBugCrawlTraineeEvent

9:00 AM - 2:00 PM US PT

Resume Review

Location: NextGen ID Lounge (Hall K Foyer)

IDBugCrawlTraineeEvent

9:15 AM - 10:00 AM US PT

20 - Maxwell Finland Lecture

Location: Ballroom (West Hall B)

Moderator: – Cleveland Clinic Foundation

Faculty: – Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTraineeTransplantCOVID-19

9:15 AM - 9:35 AM US PT

Awards Presentation

Location: Ballroom (West Hall B)

9:35 AM - 10:00 AM US PT

57 - Beta-lactamase Inhibitors: Advancements, Challenges, and Opportunities

Location: Ballroom (West Hall B)

Speaker: – Case Western Reserve University/ Louis Stokes Cleveland VA Medical Center

10:00 AM - 10:25 AM US PT

Lessons and reflections from the COVID-19 Pandemic

Location: BugHub Stage

Presenter: – Stanford University School of Medicine

BugHub Stage

10:00 AM - 10:25 AM US PT

EMPODÉRATE: Embracing Trauma-Informed Care in STI Management among Hispanic/Latinx Communities - Un Diálogo en Spanglish

Location: Global BugHub Stage

Presenter: – Harbor-UCLA Medical Center

Presenter: – Emory University School of Medicine, Division of Infectious Diseases

Global BugHub Stage

10:00 AM - 10:30 AM US PT

Mystery Case Conference

Location: NextGen ID Lounge (Hall K Foyer)

NextGen ID LoungeTraineeEvent

10:15 AM - 11:00 AM US PT

A Pentavalent Vaccine for the Prevention of Invasive Disease Caused by Neisseria meningitidis Serogroups A, B, C, W, and Y

Location: Learning Lounge 1

Sponsored Speaker: – Infectious Disease, Driscoll Children's Hospital

Affiliated Events No CE (Not Official IDWeek Programming)

10:15 AM - 11:00 AM US PT

Breaking the Cycle of Recurrence - A Preventative Treatment Option for Recurrent C. difficile Infection

Location: Learning Lounge 2

Sponsored Speaker: – University of California San Diego School of Medicine

Affiliated Events No CE (Not Official IDWeek Programming)

10:15 AM - 11:00 AM US PT

"RSV in Adults: Clinical Perspectives and Vaccination Considerations"

Location: Learning Lounge 3

Sponsored Speaker: – Wake Forest University School of Medicine

Sponsored Speaker: – MedFluencers

Affiliated Events No CE (Not Official IDWeek Programming)

10:15 AM - 11:00 AM US PT

The Changing Face of CRE: the Latest Trends in Prevalence, Subtypes, and Testing

Location: Learning Lounge 4

Sponsored Speaker: – Hartford Hospital

Affiliated Events No CE (Not Official IDWeek Programming)

10:15 AM - 11:00 AM US PT

COVID-19 Vaccination Today: Challenges and Opportunities

Location: Learning Lounge 5

Affiliated Events No CE (Not Official IDWeek Programming)

10:30 AM - 11:45 AM US PT

21 - “I Don’t See Race”: The Impact a Colorblind Constitution Has on Clinical Disparities, Medical Education and the Workforce in Infectious Diseases

Location: 515 A

Moderator: – University of Washington School of Medicine

Moderator: – Vanderbilt University Medical Center

Faculty: – Alpert Medical School of Brown University

Faculty: – University of Pennsylvania

Faculty: – Brown University

Adult IDPediatric IDTrainee

10:30 AM - 10:55 AM US PT

58 - How Did We Get Here?: How Law Impacts Population Health & Clinical Disparities in ID

Location: 515 A

Speaker: – Alpert Medical School of Brown University

10:55 AM - 11:20 AM US PT

59 - Achieving Health Equity by Creating Diversity in the era of a Colorblind Constitution

Location: 515 A

Speaker: – University of Pennsylvania

11:20 AM - 11:45 AM US PT

60 - Using Psychological Safety to Create an Inclusive Learning Environment

Location: 515 A

Speaker: – Brown University

10:30 AM - 11:45 AM US PT

22 - Beyond the 101: Pondering Perplexing Prescribing Issues

Location: 408 B

Moderator: – Johns Hopkins School of Medicine

Moderator: – University of Pittsburgh Medical Center

Faculty: – Atrium Health

Faculty: – C.S. Mott Children's Hospital, University of Michigan Health

Faculty: – Stanford Health Care

Adult IDInvestigative IDPediatric IDTraineeTransplant

10:30 AM - 10:55 AM US PT

61 - Three days of antibiotics for uncomplicated community-acquired pneumonia: Ready for prime time?

Location: 408 B

Speaker: – Atrium Health

10:55 AM - 11:20 AM US PT

62 - Do we still need to treat group A streptococcal pharyngitis for 10 days?

Location: 408 B

Speaker: – C.S. Mott Children's Hospital, University of Michigan Health

11:20 AM - 11:45 AM US PT

63 - Daptomycin and statins: To hold or not to hold

Location: 408 B

Speaker: – Stanford Health Care

10:30 AM - 11:45 AM US PT

23 - Building Your Own Clinical Prediction Model: A Bootcamp for the ID Researcher

Location: 515 B

Moderator: – University of Michigan

Moderator: – University of Maryland School of Medicine

Faculty: – University of Maryland School of Medicine

Faculty: – Emory University

Faculty: – Johns Hopkins School of Medicine

Adult IDEpi & Infection ControlTrainee

10:30 AM - 10:55 AM US PT

64 - Prediction Models 101: The Data

Location: 515 B

Speaker: – University of Maryland School of Medicine

10:55 AM - 11:20 AM US PT

65 - Prediction Models 101: The Models

Location: 515 B

Speaker: – Emory University

11:20 AM - 11:45 AM US PT

66 - Prediction Models 101: The Implementation and Automation

Location: 515 B

Speaker: – Johns Hopkins School of Medicine

10:30 AM - 11:45 AM US PT

24 - Emerging Issues in The Global Mpox Threat

Location: Ballroom (West Hall B)

Moderator: – Columbia University Irving Medical Center

Moderator: – University of Alabama-Birmingham Heersink School of Medicine

Faculty: – Institut National de Recherche Biomédicale, DRC

Faculty: – Leidos Biomedical research

Faculty: – University of California San Diego

Faculty: – Centers for Disease Control and Prevention

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTraineeTransplantCOVID-19

10:30 AM - 10:50 AM US PT

67 - Global Epidemiology of Mpox in 2024

Location: Ballroom (West Hall B)

Speaker: – Institut National de Recherche Biomédicale, DRC

10:50 AM - 11:10 AM US PT

68 - Tecovirimat for the Treatment of Mpox: A Randomized Placebo-controlled Trial in the Democratic Republic of Congo (PALM007)

Location: Ballroom (West Hall B)

Speaker: – Leidos Biomedical research

Co-Author: – The National Institute of Allergy and Infectious Diseases, National Institutes of Health

Co-Author:

11:10 AM - 11:30 AM US PT

69a - Alternative Antiviral Therapies for Treating Severe Mpox Infection

Location: Ballroom (West Hall B)

Speaker: – University of California San Diego

11:30 AM - 11:45 AM US PT

69b - Challenging Issues in Mpox Vaccination

Location: Ballroom (West Hall B)

Speaker: – Centers for Disease Control and Prevention

10:30 AM - 11:45 AM US PT

25 - Managing Infection in the Era of MDR, XDR and PDR Among Immunocompromised Hosts

Location: Petree C

Moderator: – University of North Carolina at Chapel Hill

Moderator: – Hacettepe University

Faculty: – University of California, San Francisco

Faculty: – Bellvitge University Hospital

Faculty: – University of Genova

Adult IDPediatric IDTransplant

10:30 AM - 10:55 AM US PT

70 - The impact of antimicrobial resistance in patients with hematological malignancies and hematopoietic stem cell transplant recipients

Location: Petree C

Speaker: – University of California, San Francisco

10:55 AM - 11:20 AM US PT

71 - Is it time to re-design the empiric antibacterial approach in febrile neutropenia?

Location: Petree C

Speaker: – Bellvitge University Hospital

11:20 AM - 11:45 AM US PT

72 - Quinolone prophylaxis: a double-edged sword?

Location: Petree C

Speaker: – University of Genova

10:30 AM - 11:45 AM US PT

26 - Meeting Resistance: Novel Methods for Antimicrobial Resistance

Location: 502 B

Moderator: – Johns Hopkins School of Medicine

Moderator: – Weill Cornell Medicine

Faculty: – University of Utah

Faculty: – National Institutes of Health, Clinical Center

Faculty: – Weill Cornell Medicine

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTraineeTransplant

10:30 AM - 10:55 AM US PT

73 - Viral AMR Detection

Location: 502 B

Speaker: – University of Utah

10:55 AM - 11:20 AM US PT

74 - Fungal AMR Detection

Location: 502 B

Speaker: – National Institutes of Health, Clinical Center

11:20 AM - 11:45 AM US PT

75 - Bacterial AMR Detection

Location: 502 B

Speaker: – Weill Cornell Medicine

10:30 AM - 11:45 AM US PT

27 - Preparing Your Hospital for the Next Big One

Location: 502 A

Moderator: – University of Washington/Seattle Children's Hospital

Moderator: – Emory University School of Medicine and Children's Healthcare of Atlanta

Faculty: – Emory University School of Medicine

Faculty: – University of Nebraska Medical Center

Faculty: – Children's National Hospital

Adult IDEpi & Infection ControlPediatric IDTraineeCOVID-19

10:30 AM - 10:55 AM US PT

76 - The Big Picture: Our National Framework For Caring For Patients With Special Pathogens.

Location: 502 A

Speaker: – Emory University School of Medicine

10:55 AM - 11:20 AM US PT

77 - Preparing your Hospital: From Identify, Isolate and Inform to Simulation and Training

Location: 502 A

Speaker: – University of Nebraska Medical Center

11:20 AM - 11:45 AM US PT

78 - The Bioethics of Caring for a patient with a Special Pathogen: family-centered care and beyond

Location: 502 A

Speaker: – Children's National Hospital

10:30 AM - 11:45 AM US PT

28 - State-of-the-Art HIV Care and Prevention

Location: Concourse 151

Moderator: – Division of HIV, Infectious Diseases & Global Medicine, San Francisco General Hospital, University of California, San Francisco

Moderator: – Johns Hopkins University School of Medicine

Faculty: – UCLA Center for Clinical AIDS Research & Education

Faculty: – PEPFAR, Bureau of Global Health Security and Diplomacy, US State Department

Faculty: – Ohio State University

Adult IDEpi & Infection ControlGlobal IDHIV-STD-TBPediatric IDTrainee

10:30 AM - 10:50 AM US PT

79 - What's the latest data and experience on LAI treatment and prevention?

Location: Concourse 151

Speaker: – UCLA Center for Clinical AIDS Research & Education

10:50 AM - 11:10 AM US PT

80 - PEPFAR: Strategies to accelerate towards ending the epidemic and sustaining the gains

Location: Concourse 151

Speaker: – PEPFAR, Bureau of Global Health Security and Diplomacy, US State Department

11:10 AM - 11:30 AM US PT

81 - Treatment and prevention pipeline: What's coming?

Location: Concourse 151

Speaker: – Ohio State University

11:30 AM - 11:45 AM US PT

81b - Update on Lenacapavir for PrEP: Results from the Interim Analyses of PURPOSE 1 and PURPOSE 2

Location: Concourse 151

Speaker: – Emory University

10:30 AM - 11:45 AM US PT

29 - Breaking Ground: ID Clinical Trials

Location: 404 AB

Moderator: – Duke University Medical Center

Moderator: – Houston Methodist and Weill Cornell Medical College

Adult IDInvestigative IDCOVID-19

10:30 AM - 10:45 AM US PT

82 - Comparative Evaluation of Low Versus High Doses of Rifampin for the Treatment of Staphylococcal Bone and Joint Infections: an open-label, randomized, controlled non-inferiority trial (EVRIOS)

Location: 404 AB

Presenting Author: – CHU de Rennes

Co-Author: – CHU de Rennes

Co-Author: – CHU RENNES

Co-Author: – CHU DE NANTES - HOTEL DIEU

Co-Author: – CH BRETAGNE SUD

Co-Author: – CHU BORDEAUX

Co-Author: – CHD VENDEE

Co-Author: – CHU POITIERS

Co-Author: – CH PAU

Co-Author: – CH VANNES

Co-Author: – CH SAINT-BRIEUC

Co-Author: – CHU TOULOUSE

Co-Author: – CH SAINT-MALO

Co-Author: – CHU ANGERS

Co-Author: – CHU DE CAEN

Co-Author: – Hôpital Privé Jean Mermoz - Clinique du Parc / LYON

Co-Author: – CHU RENNES

Co-Author: – CHU DE RENNES

Co-Author: – CHU de Rennes

Co-Author: – CHU BREST

Co-Author: – CHU POITIERS

Co-Author: – CHU DE RENNES

Co-Author: – CH de Pontivy

Co-Author: – CHU de Rennes

Co-Author: – CHU de Nantes

Co-Author: – CHU DE BREST

Co-Author: – CHU TOURS

10:45 AM - 11:00 AM US PT

83 - Predictors of Undetectable HDV RNA 48 weeks after completion of finite treatment with Bulevirtide and Pegylated-Interferon Alpha 2a

Location: 404 AB

Presenting Author: – M.F. Vladimirsky Moscow Regional Research and Clinical Institute, Moscow, Russian Federation

Co-Author: – LLC Clinic of Modern Medicine, Moscow, Russian Federation

Co-Author: – LLC Medical Company Hepatolog, Samara, Russian Federation

Co-Author: – Hopital Beaujob APHP, Universite de Paris, INSERM

Co-Author: – Hospital Croix Rousse

Co-Author: – Matei Bals National Institute of Infectious Diseases, Bucharest, Romania; "Carol Davila" University of Medicine and Pharmacy

Co-Author: – "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania; Dr. Victor Babes Foundation

Co-Author: – South Ural State Medical University, Chelyabinsk, Russian Federation

Co-Author: – Gilead Sciences, Inc.

Co-Author: – Hopital Saint Joseph

Co-Author: – Sechenov University

11:00 AM - 11:15 AM US PT

84 - Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections

Location: 404 AB

Presenting Author: – Emory University

Co-Author: – The George Washington University

Co-Author: – George Washington University

Co-Author: – Patient Advocates In Research (PAIR)

Co-Author: – Johnson and Johnson

Co-Author: – Duke Clinical Research Institute

Co-Author: – Johns Hopkins School of Medicine

Co-Author: – Duke University Medical Center

Co-Author: – University of California, San Francisco

Co-Author: – University of California San Francisco

Co-Author: – Duke University Medical Center

Co-Author: – Milken Institute School of Public Health

Co-Author: – Tufts University School of Medicine

11:15 AM - 11:30 AM US PT

85 - Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients

Location: 404 AB

Presenting Author: – University of Texas MD Anderson Cancer Center

Co-Author: – Amsterdam UMC

Co-Author: – InflaRx GmbH, InflaRx Pharmaceuticals, Inc.

Co-Author: – InflaRx GmbH

Co-Author: – Metranomia Clinical Research GmbH

Co-Author: – InflaRx GmbH

Co-Author: – InflaRx Pharmaceuticals, Inc.

Co-Author: – InflaRx GmbH

Co-Author: – Amsterdam UMC

11:30 AM - 11:45 AM US PT

86 - The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-< 70 years old.

Location: 404 AB

Presenting Author: – Telethon Kids Institute

Co-Author: – Telethon Kids Institute

Co-Author: – Launceston General Hospital

Co-Author: – Royal Melbourne Institute of Technology University (RMIT)

Co-Author: – University of Adelaide

Co-Author: – University of Sydney

Co-Author: – Telethon Kids Institute

Co-Author: – Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute

Co-Author: – WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia

Co-Author: – Doherty Institute

Co-Author: – University of Melbourne

Co-Author: – University of Southampton and University Hospital Southampton NHS Foundation Trust

Co-Author: – Telethon Kids Institute

Co-Author: – University of Sydney

Co-Author: – University of Western Australia School of Medicine, Perth’s Children Hospital

10:30 AM - 11:45 AM US PT

30 - Emerging Updates on COVID-19 Treatment

Location: 411

Moderator: – Indiana University School of Medicine

Moderator: – Topiwala National Medical College and BYL Nair Ch. Hospital

Adult IDPediatric IDHIV-STD-TBInvestigative IDEpi & Infection ControlTransplantCOVID-19

10:30 AM - 10:42 AM US PT

87 - Machine Learning-Guided Generation of a Potent Combination of Broadly Neutralizing Sarbecovirus Antibodies with a High Barrier to Resistance

Location: 411

Presenting Author: – Generate:Biomedicines

Co-Author: – Generate Biomedicines

Co-Author: – Generate:Biomedicines

Co-Author: – Generate Biomedicines

10:42 AM - 10:54 AM US PT

88 - Efficacy of nirmatrelvir-ritonavir in high-risk trial participants with prior SARS-CoV-2 infection or vaccination: a pooled analysis

Location: 411

Presenting Author: – Pfizer

Co-Author: – Pfizer Inc

Co-Author: – Pfizer

Co-Author: – Pfizer Inc

10:54 AM - 11:06 AM US PT

89 - First-in-human study of a novel half-life extended monoclonal antibody (GB-0669) against SARS-CoV2 and related sarbecoviruses

Location: 411

Presenting Author: – Generate Biomedicines

Co-Author: – Generate Biomedicines

Co-Author: – University of Navarra

Co-Author: – PPD part of Thermofisher

Co-Author: – Generate Biomedicines

Co-Author: – Generate:Biomedicines

Co-Author: – Generate Biomedicines

11:06 AM - 11:18 AM US PT

90 - Impact of anti-CD20 therapy on COVID-19 in immunocompromised patients: A nationwide cohort study in Korea

Location: 411

Presenting Author: – Seoul National University College of Medicine

Co-Author: – Seoul National University Hospital

Co-Author: – Dankook University

Co-Author: – Ewha Womans University College of Medicine

Co-Author: – Seoul National University College of Medicine

11:18 AM - 11:30 AM US PT

91 - Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating Pemivibart

Location: 411

Co-Author: – Invivyd, Inc.

Presenting Author: – Invivyd, Inc.

Co-Author: – Invivyd, Inc.

11:30 AM - 11:43 AM US PT

92 - Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial

Location: 411

Presenting Author: – Gilead Sciences, Inc.

Co-Author: – "Prof. Dr. Matei Bals" National Institute for Infectious Diseases Carol Davila Medicine and Pharmacy University

Co-Author: – Emergency Department, Hospital Clínico Universitario San Carlos

Co-Author: – Gilead Sciences, Inc.

Co-Author: – Gilead Sciences, Inc

Co-Author: – Gilead Sciences, Inc.

Co-Author: – Gilead Sciences Inc.

Co-Author: – Limpopo Clinical Research Initiative

Co-Author: – National Taiwan University Hospital

Co-Author: – IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University

Co-Author: – Gilead Sciences, Inc.

10:30 AM - 11:45 AM US PT

31 - Mycology Matters: Insights into Fungal Infections

Location: 403 B

Moderator: – University of Wisconsin-Madison

Moderator: – University of Kansas Medical Center

Adult IDPediatric ID

10:30 AM - 10:45 AM US PT

93 - Biomarkers of Amphotericin-Induced Complement Activation and Associated Clinical Manifestations

Location: 403 B

Co-Author: – University of California Davis Medical Center

Presenting Author: – UC Davis Health

Co-Author: – University of California Davis Medical Center

Co-Author: – UC Davis Health

Co-Author: – UC Davis

Co-Author: – UC Davis Health

10:45 AM - 11:00 AM US PT

94 - Efficacy of SCY-247, a Second-generation Triterpenoid Antifungal, in Three Murine Models of Invasive Fungal Infections

Location: 403 B

Co-Author: – SCYNEXIS, Inc.

Co-Author: – University of Texas Health San Antonio

Co-Author: – The Lundquist Institute at Harbor-UCLA Medical Center

Presenting Author: – SCYNEXIS, Inc.

11:00 AM - 11:15 AM US PT

95 - Novel Antifungal Olorofim Use in Intractable CNS and Non-CNS Disseminated Coccidioidomycosis

Location: 403 B

Presenting Author: – University of Arizona

Co-Author: – University of California Davis Medical Center

Co-Author: – Kern Medical Center

Co-Author: – University of Texas Health San Antonio

Co-Author: – Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria

Co-Author: – University of California Los Angeles, David Geffen School of Medicine

Co-Author: – Johns Hopkins University School of Medicine

Co-Author: – National Institutes of Health

Co-Author: – Oregon Health and Science University

Co-Author: – Washington University in St. Louis

Co-Author: – F2G, Ltd.

Co-Author: – University of Arizona, Valley Fever Center for Excellence

Co-Author: – F2G, Limited

11:15 AM - 11:30 AM US PT

96 - Candida albicans bloodstream infections are comprised of diverse populations of strains, including antifungal tolerant strains that emerge during treatment failure

Location: 403 B

Presenting Author: – University of Pittsburgh

Co-Author: – University of Pittsburgh

11:30 AM - 11:45 AM US PT

97 - Hemophagocytic Lymphohistiocytosis in Disseminated Histoplasmosis: an Overlooked Diagnosis

Location: 403 B

Presenting Author: – University of Arkansas for the Medical Sciences

Co-Author: – University of Arkansas for the Medical Sciences

Co-Author: – UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES

10:30 AM - 11:45 AM US PT

32 - Tackling Gram-Negative Infections in Health Care Settings

Location: 403 A

Moderator: – Centers for Disease Control and Prevention

Moderator: – Rutgers Robert Wood Johnson Medical School

Adult IDPediatric IDEpi & Infection Control

10:30 AM - 10:45 AM US PT

98 - Multispecies Outbreak of Klebsiella pneumoniae Carbapenemase-3 (KPC-3)-producing Enterobacterales in an Acute Care Hospital – Virginia, 2023-2024

Location: 403 A

Presenting Author: – Centers for Disease Control and Prevention

Co-Author: – Centers for Disease Control and Prevention

Co-Author: – Virginia Department of Health

Co-Author: – Centers for Disease Control and Prevention

Co-Author: – Virginia Department of Health

Co-Author: – Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention

Co-Author: – Centers for Disease Control and Prevention

Co-Author: – Virginia Department of General Services | Division of Consolidated Laboratory Services

Co-Author: – Virginia Department of Health

Co-Author: – Centers for Disease Control and Prevention

Co-Author: – Virginia Department of Health

10:45 AM - 11:00 AM US PT

99 - Impact of Covid-19, Divergent Genomic Modes of Transmission and Strain Replacement of Carbapenem-Resistant Organisms in a Single Hospital in Singapore over 12 years

Location: 403 A

Co-Author: – NCID

Co-Author: – Helmholtz Munich

Co-Author: – NCID

Co-Author: – Singapore General Hospital

Co-Author: – NCID

Co-Author: – Tan Tock Seng Hospital

Co-Author: – National University Hospital

Co-Author: – Singapore General Hospital

Co-Author: – Tan Tock Seng Hospital

Co-Author: – National Centre for Infectious Diseases and Tan Tock Seng Hospital, Dept of Infectious Diseases

Co-Author: – NCID

Presenting Author: – National Centre for Infectious Diseases

11:00 AM - 11:15 AM US PT

100 - Genomic epidemiology of carbapenemase-producing Enterobacter species in Toronto, Canada, 2007-2021

Location: 403 A

Presenting Author: – Sinai Health

Co-Author: – McGill University

Co-Author: – National Microbiology Laboratory

Co-Author: – Public Health Agency of Canada

Co-Author: – Ontario Agency for Health Protection and Promotion

Co-Author: – The Ottawa Hospital Research Institute

Co-Author: – North York General Hospital

Co-Author: – Shared Hospital Laboratory

Co-Author: – University of Toronto

Co-Author: – The Ottawa Hospital Research Institute

Co-Author: – Sinai Health System

Co-Author: – Public Health Ontario Laboratory

Co-Author: – Public Health Ontario

Co-Author: – University Health Network and Sinai Health Network

Co-Author: – William Osler Health System

Co-Author: – Shared Hospital Laboratory

Co-Author: – Mt. Sinai Hospital

11:15 AM - 11:30 AM US PT

101 - Patients with Carbapenem-resistant Klebsiella aerogenes and Enterobacter cloacae complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes

Location: 403 A

Presenting Author: – University of North Carolina at Chapel Hill

Co-Author: – George Washington University

Co-Author: – Emory University School of Medicine

Co-Author: – Weill Cornell Medicine

Co-Author: – Rutgers Robert Wood Johnson Medical School

Co-Author: – The University of Texas Health Science Center

Co-Author: – Montefiore Medical Center and Albert Einstein College of Medicine

Co-Author: – Renaissance School of Medicine at Stony Brook University

Co-Author: – Cleveland Clinic Foundation

Co-Author: – Wayne State University/Detroit Medical Center, John Dingell VAMC

Co-Author: – Center for Discovery and Innovation, Hackensack Meridian Health

Co-Author: – University of Buffalo

Co-Author: – Duke Clinical Research Institute

Co-Author: – Duke University School of Medicine

Co-Author: – University of North Carolina at Chapel Hill

11:30 AM - 11:45 AM US PT

102 - Carbapenemase producing organisms in Positive Blood and urine Cultures in a large New York Health System Reveals Emergence of NDM-Harboring Organisms and Associated Morbidity and Mortality

Location: 403 A

Co-Author: – Northwell Health

Co-Author: – Northwell - Long Island Jewish Medical Center

Presenting Author: – Northwell - Long Island Jewish Medical Center/North Shore University Hospital

Co-Author: – Northwell Health Laboratories

Co-Author: – Northwell Health laboratories

Co-Author: – Northwell Health Laboratories

10:30 AM - 11:45 AM US PT

33 - Challenging Cases in Pediatrics

Location: Petree D

Interactive Moderator: – Cincinnati Children's Hospital Medical Center

Interactive Moderator: – University of Chicago Comer Children's Hospital

Moderator: – Centers for Disease Control and Prevention

Panelist: – Nationwide Children's Hospital

Panelist: – Vanderbilt School of Medicine

Panelist: – Mary Bridge Children's Hospital

Panelist: – Indiana University School of Medicine

Adult IDEpi & Infection ControlGlobal IDInvestigative IDPediatric IDTraineeTransplant

10:30 AM - 11:45 AM US PT

34 - Unforgettable Cases in Adult and Pediatric Travel & Tropical Medicine

Location: Concourse 152

Interactive Moderator: – Universidad Pontificia Bolivariana

Interactive Moderator: – Hospital Infantil de Mexico, Mexico and Instituto Conmemorativo de la Salud, Panama

Panelist: – University of Colorado Anschutz Medical Campus

Panelist: – Universidad Nacional de la Amazonia Peruana

Panelist: – STONY BROOK UNIVERSITY

Panelist: – Hospital Santo Tomas

Adult IDGlobal IDInvestigative IDPediatric IDTrainee

11:15 AM - 12:00 PM US PT

Chronic Hepatitis B: Beyond the Basics

Location: Learning Lounge 1

Sponsored Speaker: – Cedars-Sinai Medical Center

Affiliated Events No CE (Not Official IDWeek Programming)

11:15 AM - 12:00 PM US PT

Explore treatment options for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Location: Learning Lounge 2

Sponsored Speaker: – St. Joseph's/Candler Health System

Sponsored Speaker: – Sharp Memorial Hospital in San Diego, California

Affiliated Events No CE (Not Official IDWeek Programming)

11:15 AM - 12:00 PM US PT

Help Protect Older Adults at Risk of Respiratory Syncytial Virus (RSV)

Location: Learning Lounge 3

Sponsored Speaker:

Affiliated Events No CE (Not Official IDWeek Programming)

12:30 PM - 12:55 PM US PT

The top 10 reason why ID physicians and clinicians are the real MVPs

Location: BugHub Stage

Presenter: – ViiV Healthcare

BugHub Stage

12:30 PM - 12:55 PM US PT

Visa Odyssey: Navigating the Infectious Disease Pathway from Fellowship to Faculty as an International Medical Graduate

Location: Global BugHub Stage

Presenter: – Harbor-UCLA Medical Center

Presenter: – The University of Alabama at Birmingham

Presenter: – University of Utah School of Medicine

Global BugHub Stage

1:00 PM - 1:25 PM US PT

Forging Paths: Expanding the ID Workforce through Combined Training Opportunities

Location: BugHub Stage

Presenter: – Indiana University School of Medicine

BugHub Stage

1:15 PM - 2:00 PM US PT

Innovations Driving Vaccine Evolution

Location: Learning Lounge 1

Sponsored Speaker: – University of North Carolina

Affiliated Events No CE (Not Official IDWeek Programming)

1:15 PM - 2:00 PM US PT

Contemporary Data and Updates to Guidelines for the Management of COVID-19

Location: Learning Lounge 2

Sponsored Speaker: – Keck School of Medicine

Affiliated Events No CE (Not Official IDWeek Programming)

1:15 PM - 2:00 PM US PT

Impact of COVID-19 on Patients

Location: Learning Lounge 3

Affiliated Events No CE (Not Official IDWeek Programming)

1:15 PM - 2:00 PM US PT

Preventing RSV Lower Respiratory Tract Disease in Infants: The First Year in Review

Location: Learning Lounge 4

Sponsored Speaker: – NYU Grossman Long Island School of Medicine / NYU Langone Health

Sponsored Speaker: – Rosalind Franklin University

Sponsored Speaker: – University of Chile

Affiliated Events No CE (Not Official IDWeek Programming)

1:15 PM - 2:00 PM US PT

Exploring an HIV-1 Treatment Option: A Clinical Data Update

Location: Learning Lounge 5

Sponsored Speaker: – AHF/ NYU Langone Medical Center

Affiliated Events No CE (Not Official IDWeek Programming)

1:45 PM - 3:00 PM US PT

68 - Challenging Consults in Mycology

Location: Concourse 151

Moderator: – University of California Davis Medical Center

Moderator: – Massachusetts General Hospital

Faculty: – University of Alabama at Birmingham

Faculty: – University of Texas Health San Antonio

Adult IDGlobal IDPediatric IDTraineeTransplant

1:45 PM - 2:10 PM US PT

126 - Ocular Fungal Infections

Location: Concourse 151

Speaker: – University of Texas Health San Antonio

2:10 PM - 2:35 PM US PT

127 - Fungal Endocarditis: Diagnosis and Management

Location: Concourse 151

Speaker: – University of Alabama at Birmingham

2:35 PM - 3:00 PM US PT

128 - Fungal Disease of The Urinary System

Location: Concourse 151

Speaker: – Massachusetts General Hospital

1:45 PM - 3:00 PM US PT

69 - Changing the Vaccine Narrative: Building Confidence Across the Lifespan

Location: Petree D

Moderator: – Baylor College of Medicine

Moderator: – Vanderbilt University Medical Center

Faculty: – WEILL CORNELL MEDICINE

Faculty: – National Foundation for Infectious Diseases

Faculty: – UC Law San Francisco

Adult IDPediatric IDTraineeTransplantCOVID-19

1:45 PM - 2:10 PM US PT

129 - Vaccine confidence:It’s not just for kids!

Location: Petree D

Speaker: – National Foundation for Infectious Diseases

2:10 PM - 2:35 PM US PT

130 - Pregnant or Breastfeeding: Vaccines?

Location: Petree D

Speaker: – WEILL CORNELL MEDICINE

2:35 PM - 3:00 PM US PT

131 - Vaccines Law: Misinformation, and Experts

Location: Petree D

Speaker: – UC Law San Francisco

1:45 PM - 3:00 PM US PT

70 - Clinical Metagenomics: Current State & Opportunities

Location: 515 B

Moderator: – Johns Hopkins School of Medicine

Moderator: – University of Cincinnati

Faculty: – Université Paris Cité

Faculty: – British Columbia Centre for Disease Control

Faculty: – Vanderbilt University Medical Center

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTransplant

1:45 PM - 2:10 PM US PT

132 - Clinical Metagenomics: Current State & Opportunities

Location: 515 B

Speaker: – Université Paris Cité

2:10 PM - 2:35 PM US PT

133 - Clinical Metagenomics: Leveraging clinical impact

Location: 515 B

Speaker: – British Columbia Centre for Disease Control

2:35 PM - 3:00 PM US PT

134 - Clinical Metagenomics: Roadmap for the future

Location: 515 B

Speaker: – Vanderbilt University Medical Center

1:45 PM - 3:00 PM US PT

71 - How to Manage Infectious Diseases in Newly Resettled and Migrating People

Location: Petree C

Moderator: – Harborview Medical Center, University of Washington

Moderator: – Hospital Infantil de Mexico, Mexico and Instituto Conmemorativo de la Salud, Panama

Faculty: – Massachusetts General Hospital Division of Infectious Diseases

Faculty: – Ryan Health

Faculty: – Baylor College of Medicine

Adult IDGlobal IDInvestigative IDHIV-STD-TBPediatric IDTrainee

1:45 PM - 2:10 PM US PT

135 - Spectrum and management of infectious diseases in newly resettled adults

Location: Petree C

Speaker: – Massachusetts General Hospital Division of Infectious Diseases

2:10 PM - 2:35 PM US PT

136 - Screening algorithms to identify latent and subclinical infections in newly resettled populations

Location: Petree C

Speaker: – Ryan Health

2:35 PM - 3:00 PM US PT

137 - Spectrum and management of infectious diseases in newly resettled children

Location: Petree C

Speaker: – Baylor College of Medicine

1:45 PM - 3:00 PM US PT

72 - Ideas Are Great, Design and Implementation Are Better

Location: 502 A

Moderator: – Dartmouth Hitchcock Medical Center

Moderator: – VA Ann Arbor Healthcare System and University of Michigan

Faculty: – Washington University

Faculty: – Columbia University Irving Medical Center and NewYork-Presbyterian Hospital

Faculty: – Medical College of Wisconsin Department of Surgery

Adult IDEpi & Infection Control

1:45 PM - 2:10 PM US PT

138 - Theory and Practice of Dissemination and Implementation Science in Infectious Diseases

Location: 502 A

Speaker: – Washington University

2:10 PM - 2:35 PM US PT

139 - Back to the Basics: Ensuring Infection Prevention Practices are Happening the Way They Should

Location: 502 A

Speaker: – Columbia University Irving Medical Center and NewYork-Presbyterian Hospital

2:35 PM - 3:00 PM US PT

140 - Overcoming Barriers in the Implementation of Evidence-Based Strategies to Reduce the Risk of Surgical Site Infections

Location: 502 A

Speaker: – Medical College of Wisconsin Department of Surgery

1:45 PM - 3:00 PM US PT

73 - Syphilis in the US: It’s Unrelenting

Location: Concourse 152

Moderator: – National Institutes of Health

Moderator: – Emory University

Faculty: – Centers for Disease Control and Prevention

Faculty: – University of Washington

Faculty: – Johns Hopkins University

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTransplant

1:45 PM - 2:10 PM US PT

73 - Bridging the Treatment Gap: Estimating the Impact of Widespread Syphilis Point-of-Care Testing

Location: Concourse 152

Speaker: – Centers for Disease Control and Prevention

2:10 PM - 2:35 PM US PT

73 - Can Doxy-PEP Implementation Reverse Syphilis Trends?

Location: Concourse 152

Speaker: – University of Washington

2:35 PM - 3:00 PM US PT

73 - Clinical Conundrums in Syphilis Management

Location: Concourse 152

Speaker: – Johns Hopkins University

1:45 PM - 3:00 PM US PT

74 - One Size Fits All? Antimicrobial Dosing in Obesity That Matters

Location: 515 A

Moderator: – University of Georgia College of Pharmacy

Moderator: – Northwestern Medicine

Faculty: – Midwestern University College of Pharmacy-Glendale Campus

Faculty: – University of Mississippi School of Pharmacy

Faculty: – Jerry H. Hodge School of Pharmacy, Texas Tech University, Dallas Campus, Dallas, Texas

Adult IDTrainee

1:45 PM - 2:10 PM US PT

145 - Obesity Dosing in Antibacterials

Location: 515 A

Speaker: – Midwestern University College of Pharmacy-Glendale Campus

2:10 PM - 2:35 PM US PT

146 - Is More Better? Dosing of Antivirals in Patients with Obesity

Location: 515 A

Speaker: – University of Mississippi School of Pharmacy

2:35 PM - 3:00 PM US PT

147 - Antifungal Dosing for Patients with Obesity

Location: 515 A

Speaker: – Jerry H. Hodge School of Pharmacy, Texas Tech University, Dallas Campus, Dallas, Texas

1:45 PM - 3:00 PM US PT

75 - Stories From the Front Line of Adult & Pediatric Traumatic Injuries

Location: 502 B

Moderator: – Centers for Disease Control and Prevention

Moderator: – Uniformed Services University of the Health Sciences

Faculty: – Walter Reed National Military Medical Center, Uniformed Services University

Faculty: – Washington University in St. Louis

Faculty: – Baylor College of Medicine

Adult IDEpi & Infection ControlGlobal IDInvestigative IDPediatric IDTrainee

1:45 PM - 2:10 PM US PT

148 - Approach to Bacterial Infections after Conflict Trauma and Burn Injuries

Location: 502 B

Speaker: – Walter Reed National Military Medical Center, Uniformed Services University

2:10 PM - 2:35 PM US PT

149 - Invasive Fungal Infections Following Military and Civilian Trauma

Location: 502 B

Speaker: – Washington University in St. Louis

2:35 PM - 3:00 PM US PT

150 - Trauma on the Homefront: Infections after Unique Pediatric Injuries

Location: 502 B

Speaker: – Baylor College of Medicine

1:45 PM - 3:00 PM US PT

76 - Strong Like Her: Women and HIV

Location: 408 B

Moderator: – University of Alabama-Birmingham Heersink School of Medicine

Moderator: – Georgetown University Medical Center, Washington, DC

Faculty: – Boston College, School of Social Work

Faculty: – Simon Fraser University

Faculty: – Kenya Medical Research Institute

HIV-STD-TBAdult IDGlobal IDPediatric IDTraineeInvestigative ID

1:45 PM - 2:10 PM US PT

151 - HIV Prevention for Black Cis-Gender Women in the US

Location: 408 B

Speaker: – Boston College, School of Social Work

2:10 PM - 2:35 PM US PT

152 - Menopause and HIV Interactions

Location: 408 B

Speaker: – Simon Fraser University

2:35 PM - 3:00 PM US PT

153 - Global HIV in Women and Children: Progress and Challenges

Location: 408 B

Speaker: – Kenya Medical Research Institute

1:45 PM - 3:00 PM US PT

77 - Beyond the Virus: HIV Therapy and Co-Morbidities Research

Location: 404 AB

Moderator: – VA North Texas Healthcare System, UT Southwestern Medical Center Dallas, TX

Moderator: – Indiana University School of Medicine

Adult IDPediatric IDHIV-STD-TBInvestigative ID

1:45 PM - 2:00 PM US PT

154 - Pharmacokinetics and Safety of GS-1720 Following Multiple Ascending Doses in a Phase 1a Study in People Without HIV-1

Location: 404 AB

Co-Author: – Gilead Sciences Inc

Co-Author: – Gilead Sciences, Inc.

Co-Author: – Gilead Sciences Inc

Co-Author: – Gilead Sciences Inc.

Co-Author: – Gilead Sciences, Inc.

Presenting Author: – Gilead Sciences Inc

Co-Author: – Gilead Sciences, Inc.

2:00 PM - 2:15 PM US PT

155 - Long-Acting Subcutaneous Lenacapavir in People with Multi-Drug Resistant HIV-1: 3-Year Results of the CAPELLA Study

Location: 404 AB

Presenting Author: – Yale School of Medicine

Co-Author: – Center for AIDS Research and Treatment

Co-Author: – Rimrock Clinic, Eisenhower Health

Co-Author: – Jacobi Medical Center, Albert Einstein College of Medicine

Co-Author: – Northstar Medical Center

Co-Author: – Howard Brown Health

Co-Author: – Georgia Department of Public Health, Coastal Health District, Chatham CARE Center, Savannah, GA, USA

Co-Author: – Triple O Research Institute

Co-Author: – St Hope Foundation

Co-Author: – Infectious Diseases Physicians, Inc.

Co-Author: – Gilead Sciences Inc.

Co-Author: – Gilead Sciences

Co-Author: – Division of Infectious Diseases, New York–Presbyterian Queens

2:15 PM - 2:30 PM US PT

156 - A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for Switch to Two-Drug Antiretroviral Regimens in Patients with HIV

Location: 404 AB

Presenting Author: – Icahn School of Medicine at Mount Sinai

Co-Author: – Montefiore Medical Center

Co-Author: – Icahn School of Medicine at Mount Sinai

Co-Author: – Mount Sinai Hospital

Co-Author: – Mount Sinai Healthcare System

Co-Author: – Icahn School of Medicine at Mount Sinai

Co-Author: – The Mount Sinai Hospital

2:30 PM - 2:45 PM US PT

157 - Long-Acting Injectable HIV Treatment in Individuals with Adherence Challenges: Real-World Insights from Southern California

Location: 404 AB

Presenting Author: – UCSD

Co-Author: – University of California, San Diego

Co-Author: – UCSD

Co-Author: – University of California San Diego

2:45 PM - 3:00 PM US PT

158 - Hepatitis B Screening Among Persons With HIV Receiving Care from the U.S. Department of Veterans Affairs

Location: 404 AB

Co-Author: – Washington D.C. VA Medical Center/George Washington University

Presenting Author: – Washington D.C. VA Medical Center/George Washington University

Co-Author: – VA Puget Sound Health Care System

Co-Author: – VA Puget Sound

Co-Author: – Office of Specialty Care Services, Veterans Health Administration

Co-Author: – Washington DC VA Medical Center/ George Washington University

1:45 PM - 3:00 PM US PT

78 - Infections in Transplant and Hematologic Malignancy Patients, Part 1

Location: 408 A

Moderator: – Fred Hutchinson Cancer Center; University of Washington

Moderator: – Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center

Adult IDTransplant

1:45 PM - 2:00 PM US PT

159 - Transplant Transmitted Infectious Among Recipients of Drowned Donor Organs: A Six Year DTAC Experience

Location: 408 A

Co-Author: – Duke University

Presenting Author: – University of California San Francisco

Co-Author: – Center for Liver Diseases, University of Chicago Medicine

Co-Author: – Mayo Clinic

Co-Author: – University of Colorado Anschutz Medical Campus

Co-Author: – Department of Pathology, Stanford University School of Medicine

Co-Author: – Cincinnati Children's Hospital

Co-Author: – University of Washington

Co-Author: – United Network for Organ Sharing

Co-Author: – Gift of Hope Organ and Tissue Donor Network

Co-Author: – Houston Methodist Hospital

Co-Author: – Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center

Co-Author: – NY Presbyterian Hospital/Columbia Univ Medical Center

Co-Author: – DCI Donor Services, Inc.

Co-Author: – Icahn School of Medicine at Mount Sinai

Co-Author: – Boston Children's Hospital

Co-Author: – Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center

Co-Author: – LifeGift Organ Donation Center

Co-Author: – Division of Pulmonary Medicine, Cedars-Sinai Medical Center

Co-Author: – United Network for Organ Sharing

Co-Author: – Emory University School of Medicine

2:00 PM - 2:15 PM US PT

160 - RSV Pre-F IgG levels in pediatric hematopoietic stem cell transplant (HCT) and leukemia/lymphoma patients

Location: 408 A

Presenting Author: – University of Washington/Seattle Children's

Co-Author: – University of Washington

Co-Author: – Seattle Children’s Hospital

2:15 PM - 2:30 PM US PT

161 - Prospective Study of Cytomegalovirus (CMV) Reactivation in Patients with Multiple Myeloma Receiving anti-CD38 and BCMA Therapies: An Interim Data Analysis

Location: 408 A

Presenting Author: – Icahn School of Medicine at Mount Sinai

Co-Author: – TCI Biostatistics Shared Resource Facility, Institute for Healthcare Delivery Science, Department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai

Co-Author: – Icahn School of Medicine at Mount Sinai

2:30 PM - 2:45 PM US PT

162 - Comparison of Clinical Risk Factors, Outcomes and Molecular Epidemiology of ESBL and non-ESBL Enterobacterales Bacteremia in Solid Organ Transplant Recipients

Location: 408 A

Presenting Author: – Henry Ford Health

Co-Author: – Henry Ford Hospital

Co-Author: – Henry Ford Health

Co-Author: – Henry Ford Hospital

2:45 PM - 3:00 PM US PT

163 - Novel Factors Predicting Mortality in Allogeneic Hematopoietic Cell Transplantation Recipients with Viral Upper Respiratory Tract Infection

Location: 408 A

Presenting Author: – National Center for Child Health and Development

Co-Author: – Fred Hutchinson Cancer Center

Co-Author: – Fred Hutchinson Cancer Center; Seattle Children's Hospital

Co-Author: – Fred Hutchinson Cancer Center

Co-Author: – University of Washington/Fred Hutchinson Cancer Research Center

Co-Author: – Fred Hutchinson Cancer Research Center; University of Washington

Co-Author: – Seattle Children’s Hospital

Co-Author: – Fred Hutchinson Cancer Center

1:45 PM - 3:00 PM US PT

79 - Late Breaker Abstract Session: Respiratory Viruses Across All Ages

Location: 403 A

Moderator: – Oregon Health & Science University

Moderator: – UVA Health

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTransplant

1:45 PM - 1:57 PM US PT

164 - Effectiveness of Adjuvanted Inactivated Influenza Vaccine versus High-Dose Inactivated Influenza Vaccine Against PCR-Confirmed Influenza among Adults ≥65 years: A Pragmatic Randomized Study

Location: 403 A

Co-Author: – Division of Research Kaiser Permanente Vaccine Study Center

Co-Author: – Kaiser Permanente Northern California

Co-Author: – Division of Research Kaiser Permanente Vaccine Study Center

Co-Author: – Kaiser Permanente Vaccine Study Center

Co-Author: – Division of Research Kaiser Permanente Vaccine Study Center

Co-Author: – CSL Seqirus

Presenting Author: – Division of Research Kaiser Permanente Vaccine Study Center

1:57 PM - 2:09 PM US PT

165 - Real-world Abrysvo Vaccine Effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related Severe Acute Respiratory Infection (ARI) Hospitalizations and Emergency Department (ED) Visits—Kaiser Permanente of Southern California (KPSC), November 2023–April 2024

Location: 403 A

Presenting Author: – Kaiser Permanente Southern California

Co-Author: – Pfizer

Co-Author: – Kaiser Permanente, Southern California

Co-Author: – Kaiser Permanente Southern California

Co-Author: – Kaiser Permanente

Co-Author: – Kaiser Permanente Southern California

Co-Author: – Pfizer Inc.

Co-Author: – Kaiser Permanente Southern California

Co-Author: – Pfizer, Inc

Co-Author: – Kaiser Permanente Southern California

Co-Author: – Kaiser Permanente, Southern California

Co-Author: – Kaiser Permanente Southern California

Co-Author: – University of California, Berkeley

Co-Author: – Kaiser Permanente, Southern California

Co-Author: – Kaiser Permanente Southern California

Co-Author: – Pfizer

Co-Author: – Pfizer Inc.

Co-Author: – Pfizer

Co-Author: – Kaiser Permanente School of Medicine

Co-Author: – Pfizer Vaccines

Co-Author: – Pfizer Biopharma Group

Co-Author: – Pfizer Vaccines

2:09 PM - 2:21 PM US PT

166 - A Phase 2b/3 Study to Evaluate the Efficacy and Safety of an Investigational Respiratory Syncytial Virus (RSV) Antibody, Clesrovimab, in Healthy Preterm and Full-Term Infants

Location: 403 A

Co-Author: – Red Cross Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa

Co-Author: – University of Colorado School of Medicine and Colorado School of Public Health

Co-Author: – Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit

Co-Author: – St. Jude Children's Research Hospital

Co-Author: – Senders Pediatrics, Cleveland, Ohio, United States

Co-Author: – Ohio Pediatric Research Association

Co-Author: – Prince of Songkla University

Co-Author: – Clinica de la Costa

Co-Author: – Hospital Padre Alberto Hurtado

Co-Author: – University Chile School of Medicine

Co-Author: – CHU de Quebec-Universite Laval

Co-Author: – Center of Postgraduate Medical Education & Bielanski Hospital

Co-Author: – Children's Hospital of Chongqing Medical University

Co-Author: – Fukui Aiiku Hospital

Co-Author: – Saitama City Hospital

Co-Author: – Merck & Co., Inc.

Co-Author: – Merck & Co., Inc., present affiliation Uniquity Bio, Malvern, PA, USA

Co-Author: – Merck Sharp & Dohme LLC - United Kingdom

Presenting Author: – Merck and Co Inc.

2:21 PM - 2:33 PM US PT

167 - Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease

Location: 403 A

Co-Author: – Red Cross Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa

Co-Author: – University Medical Centre Utrecht

Co-Author: – University of Torino

Co-Author: – Baylor College of Medicine

Presenting Author: – St. Jude Children's Research Hospital

Co-Author: – Taichung Veterans General Hospital

Co-Author: – Hospital Padre Alberto Hurtado

Co-Author: – Univeridad Del Valle

Co-Author: – National and Kapodistrian University of Athens

Co-Author: – CHU Sainte-Justine

Co-Author: – Roberto del rio children hospital

Co-Author: – Morales Vargas Centro de Investigacion

Co-Author: – Middlemore Hospital

Co-Author: – Nihon University Itabashi Hospital

Co-Author: – Merck & Co., Inc.

Co-Author: – Merck & Co., Inc., present affiliation Uniquity Bio, Malvern, PA, USA

Co-Author: – Merck & Co., Inc.

Co-Author: – Merck and Co Inc.

2:33 PM - 2:45 PM US PT

168 - Safety, Reactogenicity, and Immunogenicity of mRNA-1345, an Investigational Respiratory Syncytial Virus Vaccine, in Participants Aged 2 to < 18 Years at High Risk of Severe Disease

Location: 403 A

Presenting Author: – Moderna, Inc.

Co-Author: – Moderna, Inc.

Co-Author: – Moderna Biotech UK, Inc

2:45 PM - 2:57 PM US PT

169 - Universal Immunization Strategy Against Respiratory Syncytial Virus (RSV) Prevention in Chile with Nirsevimab during the 2024 Winter Season: First Southern Hemisphere Nationwide Effectiveness Data

Location: 403 A

Presenting Author: – Universidad de Chile

Co-Author: – Universidad de Chile

Co-Author: – Ministerio de Salud de Chile

Co-Author: – Universidad de Chile

1:45 PM - 3:00 PM US PT

80 - Topics in Pediatric Antimicrobial Stewardship

Location: 403 B

Moderator: – University of Utah

Moderator: – Intermountain Healthcare

Adult IDPediatric IDInvestigative IDGlobal IDEpi & Infection Control

1:45 PM - 2:00 PM US PT

170 - Intrapartum Antibiotic Exposure and Infectious Diseases in Childhood - A Population-based Cohort Study

Location: 403 B

Presenting Author: – University of Oulu

Co-Author: – University of Oulu

2:00 PM - 2:15 PM US PT

171 - Retrospective Review of Management of Acute Otitis Media in a Canadian Pediatric Emergency Department

Location: 403 B

Presenting Author: – Children’s Hospital of Eastern Ontario

Co-Author: – Alberta Children's Hospital

Co-Author: – Children’s Hospital of Eastern Ontario

Co-Author: – Children’s Hospital of Eastern Ontario Research Institute

Co-Author: – Children's Hospital of Eastern Ontario

2:15 PM - 2:30 PM US PT

172 - Impact of 24/7 Rapid Diagnostic Testing Pharmacist Interventions and Infectious Diseases Consultation in Pediatric Staphylococcus aureus Bacteremia

Location: 403 B

Presenting Author: – Loma Linda University School of Pharmacy

Co-Author: – Loma Linda University School of Pharmacy

Co-Author: – Children's Hospital of Philadelphia

Co-Author: – Loma Linda University Children's Hospital & School of Pharmacy

2:30 PM - 2:45 PM US PT

173 - Identifying Opportunities for Urine Culture Diagnostic Stewardship in a Pediatric Health System

Location: 403 B

Co-Author: – Children's Hospital of Philadelphia

Presenting Author: – Children's Hospital of Philadelphia

2:45 PM - 3:00 PM US PT

174 - Implementation of Methicillin Resistant Staphylococcus Aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Swabs in Pediatric Patients

Location: 403 B

Presenting Author: – Prisma Health Upstate - Greenville Memorial Hospital

Co-Author: – Prisma Health Upstate - Greenville Memorial Hospital

Co-Author: – Prisma Health

Co-Author: – Prisma Health Upstate - Greenville Memorial Hospital

1:45 PM - 3:00 PM US PT

81 - Trials and Interventions to Improve Antimicrobial Stewardship

Location: 411

Moderator: – University of Iowa

Moderator: – University Health Network

Investigative IDEpi & Infection Control

1:45 PM - 2:00 PM US PT

175 - Concordance of UTI Antibiotic Treatments with Facility-Specific Antibiograms in Nursing Homes

Location: 411

Presenting Author: – University of Wisconsin School of Medicine and Public Health

Co-Author: – University of Wisconsin School of Medicine and Public Health

Co-Author: – VA Northeast Ohio Healthcare System

Co-Author: – Louis Stokes Cleveland VA Medical Center

Co-Author: – VA Northeast Ohio Healthcare System

Co-Author: – University of Wisconsin School of Medicine and Public Health

Co-Author: – Oregon State University

Co-Author: – Yale New Haven Hospital

Co-Author: – Oregon Health and Science University

Co-Author: – Oregon State University College of Pharmacy

Co-Author: – University of Pittsburgh

Co-Author: – UPMC Senior Communities

2:00 PM - 2:15 PM US PT

176 - A Quality Improvement Endeavor to Improve Antibiotic Prescribing for Children with Acute Otitis Media in Emergency and Urgent Care Settings

Location: 411

Presenting Author: – University of Colorado/Children's Hospital Colorado

Co-Author: – University of Colorado/Children's Hospital Colorado

Co-Author: – Children's Hospital Colorado

Co-Author: – University of Colorado/Children's Hospital Colorado

Co-Author: – University of Colorado School of Medicine

2:15 PM - 2:30 PM US PT

177 - AMR-Informed Antibiotic Use Metrics

Location: 411

Presenting Author: – Washington University School of Medicine

Co-Author: – Washington University School of Medicine in St. Louis

Co-Author: – Washington University School of Medicine

Co-Author: – Washington University in St. Louis

Co-Author: – Washington University School of Medicine

2:30 PM - 2:45 PM US PT

178 - Elevating Infectious Diseases Management: Impact of an Inpatient Pharmacist-Led Tele-Antimicrobial Stewardship Program Integrated within a Health System

Location: 411

Presenting Author: – Northwell Health

Co-Author: – Northwell Health

2:45 PM - 3:00 PM US PT

179 - INSPIRE Trial: A 92-Hospital Cluster Randomized Trial of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Skin and Soft Tissue Infections

Location: 411

Presenting Author: – University of California, Irvine

Co-Author: – Texas A&M University System Health Science Center

Co-Author: – University of Massachusetts Amherst

Co-Author: – Department of Population Medicine, Harvard Pilgrim Health Care Institute

Co-Author: – HCA Healthcare

Co-Author: – Division of Infectious Diseases, University of California, Irvine School of Medicine

Co-Author: – Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School

Co-Author: – Department of Population Medicine, Harvard Pilgrim Healthcare Institute

Co-Author: – HCA Healthcare

Co-Author: – Rush Medical College

Co-Author: – HCA Healthcare

Co-Author: – Department of Population Medicine, Harvard Pilgrim Healthcare Institute

Co-Author: – HCA Healthcare

Co-Author: – Department of Population Medicine, Harvard Pilgrim Healthcare Institute

Co-Author: – Rush University Medical Center

Co-Author: – Brigham & Women's Hospital

Co-Author: – HCA Healthcare

Co-Author: – Dartmouth Hitchcock Medical Center

Co-Author: – The Joint Commission

Co-Author: – HCA Healthcare

Co-Author: – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA

Co-Author: – University of California, Irvine School of Medicine

1:45 PM - 3:00 PM US PT

82 - Challenging Cases in Infectious Diseases

Location: Ballroom (West Hall B)

Interactive Moderator: – University of Southampton

Moderator: – Emory University

Panelist: – Emory University School of Medicine

Panelist: – Warren Alpert Medical School of Brown University

Panelist: – University of Botswana

Panelist: – The University of Texas MD Anderson Cancer Center

Adult IDGlobal IDHIV-STD-TBPediatric IDTraineeTransplant

1:45 PM - 3:00 PM US PT

180 - Case Presentation #1

Location: Ballroom (West Hall B)

Case Presenter: – Jackson Memorial Hospital/ University of Miami

Co-Author: – Jackson Memorial Hospital/University of Miami

Co-Author: – Mt Sinai Medical Center

Co-Author: – Jackson Memorial Hospital/University of Miami

Co-Author: – University of Miami Hospital

Co-Author: – Jackson Memorial Hospital/University Miami

Co-Author: – Jackson Memorial Hospital/University of Miami

1:45 PM - 3:00 PM US PT

181 - Case Presentation #2

Location: Ballroom (West Hall B)

Case Presenter: – Yale School of Medicine

Co-Author: – Yale School of Medicine

1:45 PM - 3:00 PM US PT

182 - Case Presentation #3

Location: Ballroom (West Hall B)

Case Presenter: – UTMB Galveston

Co-Author: – University of Texas Medical Branch

Co-Author: – The University of Texas Medical Branch

1:45 PM - 3:00 PM US PT

183 - Case Presentation # 4

Location: Ballroom (West Hall B)

Case Presenter: – Alma Mater Studiorum - Università di Bologna

1:45 PM - 3:00 PM US PT

184 - Case Presentation # 5

Location: Ballroom (West Hall B)

Case Presenter: – Yale School of Medicine

2:00 PM - 2:30 PM US PT

IDBugCrawl: VIP Talk with Sara Dong, MD

Location: NextGen ID Lounge (Hall K Foyer)

Presenter: – Beth Israel Deaconess Medical Center & Boston Children's Hospital

IDBugCrawlTraineeEvent

2:30 PM - 3:00 PM US PT

IDBugCrawl: Mix N' Mingle

Location: NextGen ID Lounge (Hall K Foyer)

IDBugCrawlTraineeEvent

3:15 PM - 4:30 PM US PT

83 - Challenges in Preventing TB Disease Through LTBI Treatment

Location: 502 A

Moderator: – Centers for Disease Control and Prevention

Moderator: – Johns Hopkins University School of Medicine

HIV-STD-TB

3:15 PM - 3:50 PM US PT

185 - TB After 3HP: Assessing the durability of TB prevention in a high-incidence island

Location: 502 A

Speaker: – Centers for Disease Control and Prevention

3:50 PM - 4:30 PM US PT

186 - Less is More: Shortening TB Preventive Therapy

Location: 502 A

Speaker: – Johns Hopkins University School of Medicine

3:15 PM - 4:30 PM US PT

84 - Commonalities and Differences in Antimicrobial Treatment of Resistant Pathogens

Location: Concourse 152

Moderator: – Centers for Disease Control & Prevention & Einstein/ Montefiore

Moderator: – University of Pittsburgh

Faculty: – Nagasaki University

Faculty: – National Center for Global Health and Medicine

Faculty: – Intermountain Healthcare

Adult IDEpi & Infection ControlGlobal IDPediatric IDTrainee

3:15 PM - 3:40 PM US PT

187 - Epidemiology of Antimicrobial-Resistant Infections in North America and East Asia

Location: Concourse 152

Speaker: – Nagasaki University

3:40 PM - 4:05 PM US PT

188 - Antimicrobial Treatment Guidelines and their Rationale in Japan

Location: Concourse 152

Speaker: – National Center for Global Health and Medicine

4:05 PM - 4:30 PM US PT

189 - This is How we Do It: US Approach to Antimicrobial Stewardship Guidelines

Location: Concourse 152

Speaker: – Intermountain Healthcare

3:15 PM - 4:30 PM US PT

85 - Forging Provider-Public Health Partnerships to Effect Control of Challenging Infections

Location: 408 B

Moderator: – Los Angeles County Department of Public Health

Moderator: – Minnesota Department of Health

Faculty: – New York City Department of Health and Mental Hygiene

Faculty: – Los Angeles County DPH

Faculty: – Washington State Department of Health

Adult IDEpi & Infection ControlHIV-STD-TBPediatric IDTrainee

3:15 PM - 3:40 PM US PT

190 - Increasing Access to Novel Therapeutics in Public Health Emergencies

Location: 408 B

Speaker: – New York City Department of Health and Mental Hygiene

3:40 PM - 4:05 PM US PT

191 - Public health efforts to improve hepatitis C care and treatment in Los Angeles

Location: 408 B

Speaker: – Los Angeles County DPH

4:05 PM - 4:30 PM US PT

192 - Controlling the regional spread of MDROs

Location: 408 B

Speaker: – Washington State Department of Health

3:15 PM - 4:30 PM US PT

86 - Let’s Get Real: Using Virtual and Extended Reality for Infection Prevention, Control Training and Education of Front Line Staff

Location: Concourse 151

Moderator: – University of Washington School of Medicine

Moderator: – Mass General Brigham

Faculty: – Yale School of Medicine

Faculty: – Emory University School of Medicine

Faculty: – Massachusetts General Hospital

Adult IDEpi & Infection ControlPediatric IDTraineeCOVID-19

3:15 PM - 3:40 PM US PT

193 - Let’s Get Real: Using Virtual and Extended Reality for Infection Prevention, Control Training and Education of Front Line Staff

Location: Concourse 151

Speaker: – Yale School of Medicine

3:40 PM - 4:05 PM US PT

194 - Here’s a (VR) App for That: Addressing Human Factors via Headsets & Beyond

Location: Concourse 151

Speaker: – Emory University School of Medicine

4:05 PM - 4:30 PM US PT

195 - Using VR to Teach IPC Foundations and Cleaning and Disinfection of Portable Medical Equipment

Location: Concourse 151

Speaker: – Massachusetts General Hospital

3:15 PM - 4:30 PM US PT

87 - Summer Fever: Heating Up Diversity in Infectious Diseases at the Undergraduate Level

Location: Petree C

Moderator: – Emory University

Moderator: – Vanderbilt University Medical Center

Faculty: – UT Southwestern Medical Center

Faculty: – Emory University

Faculty: – UVA Health

Adult IDPediatric ID

3:15 PM - 3:40 PM US PT

196 - My Pathway: From a Summer Program to ID Faculty

Location: Petree C

Speaker: – UT Southwestern Medical Center

3:40 PM - 4:05 PM US PT

197 - Being INSPIREd: My Experience in an Undergraduate ID Summer Program

Location: Petree C

Speaker: – Emory University

4:05 PM - 4:30 PM US PT

198 - Preparing Diverse Students for Successful Careers in ID

Location: Petree C

Speaker: – UVA Health

3:15 PM - 4:30 PM US PT

88 - Thinking Outside the Box: Immunotherapy for Immunocompromised Host

Location: 502 B

Moderator: – National Institute of Allergy and infectious Diseases

Moderator: – McGill University Health Centre

Faculty: – McGill University Health Centre

Faculty: – Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Faculty: – Radboud University Medical Center

Adult IDGlobal IDInvestigative IDPediatric IDTraineeTransplantCOVID-19

3:15 PM - 3:40 PM US PT

199 - Helping the Host before things Go Viral: Immunotherapy of Viral Infections

Location: 502 B

Speaker: – McGill University Health Centre

3:40 PM - 4:05 PM US PT

200 - Immunotherapy for mycobacterial and fungal infections

Location: 502 B

Speaker: – Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health

4:05 PM - 4:30 PM US PT

201 - Immunotherapy for bacterial infections

Location: 502 B

Speaker: – Radboud University Medical Center

3:15 PM - 4:30 PM US PT

89 - Advances in Health Care-Associated C. difficile

Location: 403 A

Moderator: – Ann & Robert H. Lurie Children's Hospital of Chicago

Moderator: – Medical College of Wisconsin

Adult IDPediatric IDEpi & Infection Control

3:15 PM - 3:30 PM US PT

202 - Targeting Clostridioides difficile Infection Prevention Efforts with Artificial Intelligence

Location: 403 A

Presenting Author: – Emory University

Co-Author: – University of Michigan

Co-Author: – University of Michigan - Michigan Medicine

Co-Author: – University of Michigan

Co-Author: – Michigan Medicine

Co-Author: – University of Michigan - Michigan Medicine

Co-Author: – VA Ann Arbor Healthcare System and University of Michigan

Co-Author: – University of Michigan - Michigan Medicine

Co-Author: – Michigan Medicine

Co-Author: – University of Michigan

3:30 PM - 3:45 PM US PT

203 - Screening and Targeted Prophylaxis for Clostridioides Difficile Infection: STOP-CDI

Location: 403 A

Presenting Author: – University of Pennsylvania

Co-Author: – FDA

Co-Author: – University of Pennsylvania

Co-Author: – University of Pennsylvania Perelman School of Medicine

Co-Author: – University of Pennsylvania

Co-Author: – Hospital of the University of Pennsylvania

3:45 PM - 4:00 PM US PT

204 - Clostridioides difficile screening among asymptomatic carriers admitted for bone marrow transplantation: Navigating optimal stewardship strategies

Location: 403 A

Presenting Author: – Ohio State University Medical Center/Nationwide Children's Hospital

Co-Author: – The Ohio State University

Co-Author: – The Ohio State Wexner Medical Center

Co-Author: – The Ohio State University

Co-Author: – Ohio State University Wexner Medical Center

Co-Author: – The Ohio State Univiersity Wexner Medical Center

Co-Author: – The Ohio State University

4:00 PM - 4:15 PM US PT

205 - Utilization of the Four Themes of the CDC/ATSDR SVI Interactive Map in Assessing Initial Clostridioides difficile Infection Outcomes

Location: 403 A

Presenting Author: – Loma Linda University Health

Co-Author: – Loma Linda University Medical Center

Co-Author: – University of California San Diego

4:15 PM - 4:30 PM US PT

206 - A Cluster Randomized Trial Evaluating Universal Gloving for Reducing Clostridioides difficile Acquisition and Infection in VA: The GloRI Study

Location: 403 A

Presenting Author: – Wm. S. Middleton Memorial VA Hospital

Co-Author: – Edward Hines, Jr. VA Medical Center

Co-Author: – Madison VA Hospital

Co-Author: – Bronx VA

Co-Author: – University of Wisconsin School of Medicine and Public Health

Co-Author: – West Haven VA

Co-Author: – University of Wisconsin - Madison

Co-Author: – Northwestern University and VA

Co-Author: – Bronx VA Hospital

Co-Author: – University of Maryland School of Medicine

Co-Author: – Villanova University

Co-Author: – Milwaukee VA Hospital

Co-Author: – Edward Hines, Jr. VA Hospital and Loyola University Medical Center

Co-Author: – VA Portland Health Care System

Co-Author: – Washington DC VA Medical Center/ George Washington University

Co-Author: – University of Wisconsin School of Medicine and Public Health

3:15 PM - 4:30 PM US PT

90 - Analyzing Antibiotics: B-Lactam Therapeutic Drug Monitoring

Location: 403 B

Moderator: – Johns Hopkins University

Moderator: – University of Houston

Adult IDInvestigative ID

3:15 PM - 3:30 PM US PT

207 - Ex vivo Assessment of Cefepime (FEP) Clearance during Continuous Renal Replacement Therapy (CRRT) and Clinical Validation of Optimized Dosing Regimens

Location: 403 B

Presenting Author: – Hartford Hospital

Co-Author: – Hartford Hospital

3:30 PM - 3:45 PM US PT

208 - Exposure-response relationship of ceftazidime/avibactam in adults with central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae: a prospective observational study

Location: 403 B

Presenting Author: – Huashan Hospital, Fudan University

Co-Author: – Huashan Hospital, Fudan University

3:45 PM - 4:00 PM US PT

209 - Population Pharmacokinetics of Meropenem-Vaborbactam in Acutely Ill Hospitalized Patients with Various Degrees of Renal Dysfunction

Location: 403 B

Presenting Author: – Midwestern University

Co-Author: – Midwestern University

Co-Author: – University of Pittsburgh Medical Center

Co-Author: – University of Pittsburgh

Co-Author: – University of Pittsburgh Medical Center

Co-Author: – The Saban Research Institute, Children’s Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA

Co-Author: – University of Pittsburgh

Co-Author: – Midwestern University

4:00 PM - 4:15 PM US PT

210 - Implementation of a Pharmacist Driven Beta-lactam Therapeutic Drug Monitoring Program with Daily Result Reporting: Initial Experiences and Challenges Faced

Location: 403 B

Presenting Author: – Northwestern Memorial Hospital

Co-Author: – Northwestern Memorial Hospital

Co-Author: – Northwestern University Feinberg School of Medicine

Co-Author: – Midwestern University

4:15 PM - 4:30 PM US PT

211 - Defining Optimal Sampling Times for Cefepime Therapeutic Drug Monitoring in Clinical Practice

Location: 403 B

Presenting Author: – Midwestern University

Co-Author: – University of Pittsburgh Medical Center

Co-Author: – University of Pittsburgh

Co-Author: – Northwestern Memorial Hospital

Co-Author: – Northwestern University Feinberg School of Medicine

Co-Author: – InsightRX

Co-Author: – Centre for Translational Anti-infective Pharmacodynamics, UQ Centre for Clinical Research

Co-Author: – UQ Centre for Clinical Research, Faculty of Medicine

Co-Author: – Indiana University School of Medicine

Co-Author: – The Saban Research Institute, Children’s Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA

Co-Author: – Midwestern University

3:15 PM - 4:30 PM US PT

91 - Intimate Insights: Sexually Transmitted Infection Studies

Location: 411

Moderator: – University of Iowa/Iowa City VAMC

Moderator: – Thomas Jefferson University Hospital

Adult ID

3:15 PM - 3:27 PM US PT

212 - Gonorrhea and Chlamydia Opt-Out Screening of Justice-Involved Females During Intake at the Los Angeles County Jail: The Pivotal Role of Correctional Health Systems

Location: 411

Presenting Author: – Los Angeles County Department of Correctional Health Services

Co-Author: – Los Angeles County Department of Health Services, Division of Correctional Health Services

Co-Author: – Lundquist Institute at Harbor-UCLA Medical Center

Co-Author: – Harbor-UCLA Medical Center

Co-Author: – Los Angeles County Department of Health Services, Division of Correctional Health Services

Co-Author: – Los Angeles County Department of Correctional Health Services

3:27 PM - 3:39 PM US PT

213 - Electronic Visit (E-visit) Use for Sexually Transmitted Infection (STI) Testing in a Large Integrated Healthcare System

Location: 411

Presenting Author: – Kaiser Permanente South San Francisco

Co-Author: – The Permanente Medical Group

Co-Author: – Kaiser Permanente Division of Research

Co-Author: – Kaiser Permanente

Co-Author: – Kaiser Permanente San Francisco

Co-Author: – Kaiser Permanente Northern California

Co-Author: – Kaiser Oakland Internal Medicine Residency Program

Co-Author: – Kaiser Permanente

Co-Author: – The Permanente Medical Group

Co-Author: – Kaiser Permanente

Co-Author: – Kaiser Oakland Department of Infectious Diseases

3:39 PM - 3:51 PM US PT

214 - Clinical Characteristics and Outcomes of Patients Treated with Tecovirimat for Mpox Disease: A Large Cohort in New York City

Location: 411

Co-Author: – New York City Department of Health

Co-Author: – New York City Department of Health and Mental Hygiene

Co-Author: – NYC DOHMH

Co-Author: – Weill Cornell Medical College

Co-Author: – NYU Grossman School of Medicine

Co-Author: – The Mount Sinai Hospital

Co-Author: – Callen-Lorde Community Health Center

Co-Author: – New York City Department of Health and Mental Hygiene

Co-Author: – Weill Cornell Medicine

Co-Author: – Callen Lorde Community Health Center

Co-Author: – Callen-Lorde Community Health Center

Co-Author: – NYU Langone

Co-Author: – Harlem Hospital Center/Columbia University

Co-Author: – New York University

Co-Author: – New York Presbyterian - Columbia University Irving Medical Center

Co-Author: – New York City Department of Health and Mental Hygiene

Co-Author: – Montefiore Medical Center / Albert Einstein College of Medicine

Co-Author: – NYU Grossman School of Medicine

Co-Author: – Icahn School of Medicine at Mount Sinai

Co-Author: – NYU Grossman School of Medicine

Co-Author: – Callen-Lorde Community Health Center

Co-Author: – Montefiore Medical Center

Co-Author: – NYC Health + Hospitals/ Harlem Columbia University

Co-Author: – Waterbury Hospital

Co-Author: – Montefiore Medical Center and Albert Einstein College of Medicine

Co-Author: – Icahn School of Medicine at Mount Sinai

Co-Author: – Columbia University Irving Medical Center

Presenting Author: – New York City Department of Health and Mental Hygiene

3:51 PM - 4:03 PM US PT

215 - Trends in Syphilis and the Impact of the COVID-19 Pandemic in Florida: A multiscale joinpoint regression analysis

Location: 411

Presenting Author: – Pine Crest School

Co-Author: – Pine Crest School

Co-Author: – Memorial Healthcare System

4:03 PM - 4:15 PM US PT

216 - Effectiveness of JYNNEOS Vaccination in Preventing Lesion Dissemination Among Individuals with Confirmed Mpox Infection

Location: 411

Presenting Author: – University of California Berkeley

Co-Author: – California Department of Public Health

Co-Author: – Sexually Transmitted Diseases Control Branch

Co-Author: – California Department of Public Health

Co-Author: – CDPH

Co-Author: – University of California Berkeley

Co-Author: – California Department of Public Health

4:15 PM - 4:27 PM US PT

217 - Preliminary Results from a Clinical Trial Comparing the Efficacy of Cefixime Versus Penicillin G for the Treatment of Early Syphilis

Location: 411

Presenting Author: – University of Southern California Keck School of Medicine

Co-Author: – AIDS Healthcare Foundation

Co-Author: – University of Southern California

Co-Author: – Universidad Peruana Cayetano Heredia

Co-Author: – Keck School of Medicine of USC

3:15 PM - 4:30 PM US PT

92 - Vaccine in Young and Old

Location: 404 AB

Moderator: – National Institutes of Health

Moderator: – University of Washington

Adult IDPediatric IDTransplant

3:15 PM - 3:30 PM US PT

218 - Attenuated PreFusion F Antibody Response to RSV Vaccines in Solid Organ Transplant Recipients

Location: 404 AB

Presenting Author: – Johns Hopkins University

Co-Author: – Johns Hopkins University

Co-Author: – Johns Hopkins

3:30 PM - 3:45 PM US PT

219 - Robust and Consistent Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) Across Different Age Ranges and Frailty Status in Older Adults

Location: 404 AB

Co-Author: – Ghent University and Ghent University Hospital, Ghent, Belgium

Co-Author: – Senior Clinical Trials Inc., Laguna Hills, CA, United States

Co-Author: – Università Campus Bio-Medico di Roma, Rome, Italy

Co-Author: – The Catholic University of Korea, Seoul, South Korea

Co-Author: – University of Ferrara, St. Anna University Hospital, Ferrara, Italy

Co-Author: – National Institutes of Health

Co-Author: – GSK, Wavre, Belgium

Co-Author: – GSK

Co-Author: – GSK, Rixensart, Belgium

Co-Author: – GlaxoSmithKline Biologicals

Co-Author: – GSK, Wavre, Belgium

Presenting Author: – GSK, Wavre, Belgium

3:45 PM - 4:00 PM US PT

220 - A Phase 2 Double-Blind, Placebo-Controlled Study Showing Oral Tableted Norovirus Vaccine VXA-G1.1-NN is Immunogenic, Efficacious, and Reduces Viral Shedding Following Norovirus Challenge

Location: 404 AB

Co-Author: – Vaxart, Inc

Co-Author: – Vaxart Inc

Co-Author: – Vaxart Inc.

Co-Author: – Vaxart

Co-Author: – Vaxart, Inc.

Presenting Author: – Vaxart

Co-Author: – VAXART

4:00 PM - 4:15 PM US PT

221 - Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) when Co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US and Puerto Rico

Location: 404 AB

Co-Author:

Co-Author: – Sanofi Pasteur

Presenting Author: – Sanofi

Co-Author: – Sanofi

4:15 PM - 4:30 PM US PT

222 - Effectiveness of the Original BNT162b2 Messenger RNA Vaccine Against COVID-19 Omicron Infection in Children Aged 6 Months to 4 Years in Japan

Location: 404 AB

Presenting Author: – Niigata University Graduate School of Medical and Dental Sciences

Co-Author: – Niigata University Graduate School of Medical and Dental Sciences

Co-Author: – Department of Pediatrics , Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

Co-Author: – Niigata University

Co-Author: – Shin Pediatric Clinic

Co-Author: – Ikarashi Pediatric Clinic

Co-Author: – Okugawa Pediatric Clinic

Co-Author: – Otsuka Pediatric Clinic

Co-Author: – Sasagawa Pediatric Clinic

Co-Author: – Sakauchi Pediatric Clinic

Co-Author: – Sato Pediatric Clinic

Co-Author: – Seikyou Pediatric Clinic

Co-Author: – Ota Pediatric Clinic

Co-Author: – Niigata Prefectural Institute of Public Health and Environmental Science

Co-Author: – Niigata University

3:15 PM - 4:30 PM US PT

93 - Caroline B. Hall Lecture

Location: Ballroom (West Hall B)

Moderator: – University of Colorado/Children's Hospital Colorado

Moderator: – Indiana University

Moderator: – Arkansas Children's, University of Arkansas for Medical Sciences

Faculty: – Baylor College of Medicine

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTraineeTransplantCOVID-19

3:15 PM - 3:30 PM US PT

223 - PIDS FEATURED ORAL ABSTRACT: Assessment of Bacterial Pathogens in Young Children with Acute Otitis Media: A Prospective Cohort Study in the United States (US)

Location: Ballroom (West Hall B)

Presenting Author: – University of Pittsburgh

Co-Author: – University of Pittsburgh

Co-Author: – University of Pittsburgh School of Medicine

Co-Author: – Merck & Co., Inc.

Co-Author: – University of Pittsburgh School of Medicine

3:30 PM - 3:45 PM US PT

Awards Presentation

Location: Ballroom (West Hall B)

3:45 PM - 4:30 PM US PT

224 - Congenital Cytomegalovirus (CMV): Playing the Long Game

Location: Ballroom (West Hall B)

Speaker: – Baylor College of Medicine

3:15 PM - 4:30 PM US PT

94 - A Day With the Stewardship Pager

Location: 515 B

Interactive Moderator: – Johns Hopkins School of Medicine

Interactive Moderator: – Trinity Health Grand Rapids

Panelist: – University of Utah Health

Panelist: – Children's Hospital of Philadelphia

Panelist: – MUSC Health

Panelist: – Brigham and Women's Hospital

Adult IDInvestigative IDPediatric IDTraineeTransplant

3:15 PM - 4:30 PM US PT

95 - Advances and Controversies in Orthopedic Infections: A Multidisciplinary Discussion

Location: Petree D

Interactive Moderator: – University of Michigan

Interactive Moderator: – University of Maryland School of Medicine

Panelist: – Mayo Clinic

Panelist: – Massachusetts General Hospital

Panelist: – Stanford University

Adult IDEpi & Infection ControlPediatric ID

3:15 PM - 4:30 PM US PT

96 - Status Neutral Squabbles: Weight Gain on ART: Add a Weight-Loss Agent vs. Switch ART? And Should We Invest in nPEP as a Tool to EHE?

Location: 515 A

Interactive Moderator: – Orlando Immunology Center

Interactive Moderator: – Geisinger Medical Center

Moderator: – Emory University

Faculty: – Emory University

Faculty: – University of Colorado Anschutz Medical Campus

Faculty: – Division of Infectious Diseases, Department of Medicine, St. Michael's Hospital

Faculty: – University of Alabama of Birmingham

Adult IDGlobal IDInvestigative IDHIV-STD-TBPediatric IDTrainee

3:15 PM - 3:33 PM US PT

225 - Weight gain on ART: Switch ART

Location: 515 A

Debate Style Speaker: – Emory University

3:33 PM - 3:51 PM US PT

226 - Weight gain on ART: Add weight loss agent

Location: 515 A

Debate Style Speaker: – University of Colorado Anschutz Medical Campus

3:51 PM - 4:09 PM US PT

227 - Should we invest in post-exposure prophylaxis (PEP) as a tool to end the HIV epidemic? Pro

Location: 515 A

Debate Style Speaker: – Division of Infectious Diseases, Department of Medicine, St. Michael's Hospital

4:09 PM - 4:30 PM US PT

228 - Should we invest in non-occupational post-exposure prophylaxis (nPEP) as a tool to end the HIV epidemic? Con

Location: 515 A

Debate Style Speaker: – University of Alabama of Birmingham

4:30 PM - 4:55 PM US PT

Insights from SHEA Grassroots Advocates

Location: BugHub Stage

BugHub Stage

4:45 PM - 6:00 PM US PT

97 - Joseph E. Smadel Lecture

Location: Ballroom (West Hall B)

Moderator: – National Institutes of Health

Faculty: – University of Utah

Adult IDEpi & Infection ControlGlobal IDInvestigative IDHIV-STD-TBPediatric IDTraineeTransplantCOVID-19

4:45 PM - 5:05 PM US PT

230 - Awards Presentation

Location: Ballroom (West Hall B)

5:05 PM - 5:20 PM US PT

229 - IDSA FEATURED ORAL ABSTRACT: MVA-BN Induces a Low Avidity, Non-Durable Humoral Response Against Mpox Virus

Location: Ballroom (West Hall B)

Presenting Author: – NYU Grossman School of Medicine

Co-Author: – New York University Grossman School of Medicine

Co-Author: – NYU Grossman School of Medicine

Co-Author: – NYU Langone Health

Co-Author: – NYU Langone Vaccine Center

Co-Author: – Nyusim

Co-Author: – NYU Langone Health

Co-Author: – New York University Grossman School of Medicine

Co-Author: – NYC Department of Health and Mental Hygiene

Co-Author: – NYU Grossman School of Medicine

Co-Author: – NYU Langone Health

Co-Author: – NYU Grossman School of Medicine

5:20 PM - 5:45 PM US PT

230 - Advances and Challenges in Fungal Diagnostics

Location: Ballroom (West Hall B)

Speaker: – University of Utah

6:00 PM - 8:00 PM US PT

Career Fair

Location: BugHub

Event

6:00 PM - 8:00 PM US PT

IDSA Immunocompromised Host Community of Practice Reception

Location: JW Marriott - Platinum Ballroom A-C

Event

6:30 PM - 7:30 PM US PT

SHEA Business Meeting Reception

Location: Intercontinental - Hollywood Ballroom I-II

Event

6:30 PM - 9:30 PM US PT

Dr. George W Counts Interest Group Dinner

Location: The Palm Restaurant

Event

7:00 PM - 9:00 PM US PT

HIV Management: Clinical Case Conundrums

Location: JW Marriott - Platinum Ballroom E

Sponsored Moderator: – Brigham and Women’s Hospital; Harvard Medical School

Sponsored Speaker: – UCLA Center for Clinical AIDS Research & Education

Sponsored Speaker: – Orlando Immunology Center; Emory Rollins School of Public Health

Sponsored Speaker: – Washington University in St. Louis

Affiliated Events CE (Not Official IDWeek Programming)